Bone Loss after Allogeneic Haematopoietic Stem Cell Transplantation: A Pilot Study on the Use of Zoledronic Acid

Purpose. Bone loss is a common phenomenon following allogeneic haematopoietic stem cell transplantation (allo-HSCT). The study aimed on tolerance and efficacy of zoledronic acid (ZA) in patients after allo-HSCT. Methods. 40 patients' with osteoporosis or osteopenia were recruited on this phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Hausmann, Andreas, Hill, Wolfgang, Stemmler, Hans Joachim, Ledderose, Georg, Baur-Melnyk, Andrea, Fritsch, Susanne, Ullmann, Johanna, Kolb, Hans-Jochem, Geiger, Sandra, Tischer, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328888/
https://www.ncbi.nlm.nih.gov/pubmed/22550587
http://dx.doi.org/10.1155/2012/858590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328888/
https://www.ncbi.nlm.nih.gov/pubmed/22550587
http://dx.doi.org/10.1155/2012/858590

Ejemplares similares